Citadel Advisors’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Hold |
937,488
| – | – | ﹤0.01% | 3054 |
|
|
2025
Q1 | $924K | Buy |
+937,488
| New | +$924K | ﹤0.01% | 3373 |
|
|
2024
Q4 | – | Sell |
-102,860
| Closed | -$354K | – | 6650 |
|
|
2024
Q3 | $354K | Sell |
102,860
-37,501
| -27% | -$129K | ﹤0.01% | 4125 |
|
|
2024
Q2 | $463K | Buy |
140,361
+73,790
| +111% | +$244K | ﹤0.01% | 3852 |
|
|
2024
Q1 | $314K | Buy |
66,571
+19,945
| +43% | +$93.9K | ﹤0.01% | 4357 |
|
|
2023
Q4 | $340K | Sell |
46,626
-72,239
| -61% | -$527K | ﹤0.01% | 4117 |
|
|
2023
Q3 | $1.44M | Sell |
118,865
-95,763
| -45% | -$1.16M | ﹤0.01% | 2695 |
|
|
2023
Q2 | $2.27M | Buy |
214,628
+204,970
| +2,122% | +$2.17M | ﹤0.01% | 2331 |
|
|
2023
Q1 | $95K | Sell |
9,658
-182,820
| -95% | -$1.8M | ﹤0.01% | 4924 |
|
|
2022
Q4 | $2.83M | Sell |
192,478
-120,798
| -39% | -$1.78M | ﹤0.01% | 2274 |
|
|
2022
Q3 | $3.8M | Buy |
313,276
+172,256
| +122% | +$2.09M | ﹤0.01% | 2109 |
|
|
2022
Q2 | $1.97M | Buy |
141,020
+82,093
| +139% | +$1.15M | ﹤0.01% | 2753 |
|
|
2022
Q1 | $839K | Sell |
58,927
-5,686
| -9% | -$81K | ﹤0.01% | 3917 |
|
|
2021
Q4 | $1.36M | Sell |
64,613
-1,436
| -2% | -$30.3K | ﹤0.01% | 3440 |
|
|
2021
Q3 | $1.73M | Sell |
66,049
-150,651
| -70% | -$3.95M | ﹤0.01% | 3174 |
|
|
2021
Q2 | $6.76M | Buy |
216,700
+184,378
| +570% | +$5.75M | ﹤0.01% | 1822 |
|
|
2021
Q1 | $992K | Buy |
32,322
+20,770
| +180% | +$637K | ﹤0.01% | 3937 |
|
|
2020
Q4 | $396K | Buy |
11,552
+3,646
| +46% | +$125K | ﹤0.01% | 4035 |
|
|
2020
Q3 | $243K | Sell |
7,906
-14,659
| -65% | -$451K | ﹤0.01% | 3977 |
|
|
2020
Q2 | $700K | Buy |
+22,565
| New | +$700K | ﹤0.01% | 3172 |
|